Annual Revenue
$316.61 M
+$145.06 M+84.56%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual revenue is $316.61 million, with the most recent change of +$145.06 million (+84.56%) on December 31, 2022.
- During the last 3 years, EGRX annual revenue has risen by +$120.72 million (+61.62%).
- EGRX annual revenue is now at all-time high.
Performance
EGRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$64.65 M
-$1.66 M-2.50%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly revenue is $64.65 million, with the most recent change of -$1.66 million (-2.50%) on June 30, 2023.
- Over the past year, EGRX quarterly revenue has dropped by -$9.49 million (-12.80%).
- EGRX quarterly revenue is now -44.21% below its all-time high of $115.87 million, reached on March 31, 2022.
Performance
EGRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$257.55 M
-$9.49 M-3.55%
June 30, 2023
Summary
- As of February 8, 2025, EGRX TTM revenue is $257.55 million, with the most recent change of -$9.49 million (-3.55%) on June 30, 2023.
- Over the past year, EGRX TTM revenue has dropped by -$14.63 million (-5.38%).
- EGRX TTM revenue is now -18.65% below its all-time high of $316.61 million, reached on December 31, 2022.
Performance
EGRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EGRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +84.6% | -12.8% | -5.4% |
| 3 y3 years | +61.6% | +54.1% | +45.2% |
| 5 y5 years | +33.8% | +9.0% | +31.5% |
EGRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +84.6% | -44.2% | +52.8% | -18.6% | +50.1% |
| 5 y | 5-year | at high | +84.6% | -44.2% | +62.2% | -18.6% | +50.1% |
| alltime | all time | at high | >+9999.0% | -44.2% | +4258.8% | -18.6% | >+9999.0% |
Eagle Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $64.65 M(-2.5%) | $257.55 M(-3.6%) |
| Mar 2023 | - | $66.31 M(+9.2%) | $267.04 M(-15.7%) |
| Dec 2022 | $316.61 M(+84.6%) | $60.70 M(-7.9%) | $316.61 M(+6.2%) |
| Sep 2022 | - | $65.90 M(-11.1%) | $298.23 M(+9.6%) |
| Jun 2022 | - | $74.14 M(-36.0%) | $272.18 M(+10.6%) |
| Mar 2022 | - | $115.87 M(+173.8%) | $246.17 M(+43.5%) |
| Dec 2021 | $171.55 M(-8.7%) | $42.32 M(+6.2%) | $171.55 M(-4.2%) |
| Sep 2021 | - | $39.85 M(-17.2%) | $179.14 M(-5.3%) |
| Jun 2021 | - | $48.12 M(+16.7%) | $189.22 M(+3.4%) |
| Mar 2021 | - | $41.25 M(-17.4%) | $183.03 M(-2.5%) |
| Dec 2020 | $187.80 M(-4.1%) | $49.92 M(-0.0%) | $187.80 M(+0.9%) |
| Sep 2020 | - | $49.93 M(+19.1%) | $186.14 M(+5.0%) |
| Jun 2020 | - | $41.94 M(-8.9%) | $177.36 M(-7.7%) |
| Mar 2020 | - | $46.02 M(-4.6%) | $192.13 M(-1.9%) |
| Dec 2019 | $195.89 M(-8.2%) | $48.26 M(+17.3%) | $195.89 M(-3.8%) |
| Sep 2019 | - | $41.15 M(-27.4%) | $203.69 M(-4.8%) |
| Jun 2019 | - | $56.70 M(+13.9%) | $213.88 M(-1.2%) |
| Mar 2019 | - | $49.78 M(-11.2%) | $216.47 M(+1.5%) |
| Dec 2018 | $213.31 M(-9.9%) | $56.05 M(+9.2%) | $213.31 M(+4.5%) |
| Sep 2018 | - | $51.34 M(-13.4%) | $204.04 M(-5.4%) |
| Jun 2018 | - | $59.30 M(+27.2%) | $215.73 M(+4.4%) |
| Mar 2018 | - | $46.63 M(-0.3%) | $206.54 M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $236.71 M(+24.9%) | $46.78 M(-25.8%) | $236.71 M(-12.7%) |
| Sep 2017 | - | $63.02 M(+25.8%) | $271.06 M(+10.2%) |
| Jun 2017 | - | $50.11 M(-34.7%) | $245.88 M(+3.9%) |
| Mar 2017 | - | $76.79 M(-5.4%) | $236.69 M(+24.9%) |
| Dec 2016 | $189.48 M(+186.1%) | $81.14 M(+114.5%) | $189.48 M(+49.8%) |
| Sep 2016 | - | $37.83 M(-7.5%) | $126.52 M(+34.0%) |
| Jun 2016 | - | $40.92 M(+38.3%) | $94.43 M(+58.7%) |
| Mar 2016 | - | $29.59 M(+62.8%) | $59.51 M(-10.1%) |
| Dec 2015 | $66.23 M(+246.8%) | $18.18 M(+217.0%) | $66.23 M(+23.5%) |
| Sep 2015 | - | $5.74 M(-4.4%) | $53.65 M(+5.8%) |
| Jun 2015 | - | $6.00 M(-83.5%) | $50.72 M(+0.4%) |
| Mar 2015 | - | $36.31 M(+548.4%) | $50.51 M(+163.0%) |
| Dec 2014 | - | $5.60 M(+99.2%) | $19.21 M(+0.6%) |
| Sep 2014 | $19.10 M(+39.6%) | $2.81 M(-51.5%) | $19.10 M(-8.7%) |
| Jun 2014 | - | $5.79 M(+15.7%) | $20.93 M(+3.5%) |
| Mar 2014 | - | $5.00 M(-8.9%) | $20.21 M(+14.3%) |
| Dec 2013 | - | $5.49 M(+18.4%) | $17.69 M(+29.3%) |
| Sep 2013 | $13.68 M(+438.8%) | $4.64 M(-8.6%) | $13.68 M(+51.3%) |
| Jun 2013 | - | $5.08 M(+104.6%) | $9.04 M(+128.0%) |
| Mar 2013 | - | $2.48 M(+67.3%) | $3.96 M(+167.3%) |
| Dec 2012 | - | $1.48 M | $1.48 M |
| Sep 2012 | $2.54 M | - | - |
FAQ
- What is Eagle Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual revenue year-on-year change?
- What is Eagle Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly revenue year-on-year change?
- What is Eagle Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM revenue year-on-year change?
What is Eagle Pharmaceuticals annual revenue?
The current annual revenue of EGRX is $316.61 M
What is the all time high annual revenue for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual revenue is $316.61 M
What is Eagle Pharmaceuticals annual revenue year-on-year change?
Over the past year, EGRX annual revenue has changed by +$145.06 M (+84.56%)
What is Eagle Pharmaceuticals quarterly revenue?
The current quarterly revenue of EGRX is $64.65 M
What is the all time high quarterly revenue for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly revenue is $115.87 M
What is Eagle Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, EGRX quarterly revenue has changed by -$9.49 M (-12.80%)
What is Eagle Pharmaceuticals TTM revenue?
The current TTM revenue of EGRX is $257.55 M
What is the all time high TTM revenue for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM revenue is $316.61 M
What is Eagle Pharmaceuticals TTM revenue year-on-year change?
Over the past year, EGRX TTM revenue has changed by -$14.63 M (-5.38%)